Preface on Lung Cancer Immunotherapy
Immunotherapy for lung cancer
Abstract
This issue of Translational Lung Cancer Research (TLCR) focuses on advances in lung cancer immunotherapy. Lung cancer has traditionally been considered to be an immune resistant disease. However, great advances have been made in recent years in the field of immunotherapy for solid tumors (1) and today there are several approved drugs available which modulate the immune response (1).
